BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 23794286)

  • 1. Interventions for cutaneous Bowen's disease.
    Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for basal cell carcinoma of the skin.
    Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for actinic keratoses.
    Gupta AK; Paquet M; Villanueva E; Brintnell W
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for basal cell carcinoma of the skin.
    Bath-Hextall FJ; Perkins W; Bong J; Williams HC
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003412. PubMed ID: 17253489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions.
    Gómez C; Cobos M; Alberdi E
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():295-299. PubMed ID: 30986539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial.
    Ahmady S; Nelemans PJ; Kelleners-Smeets NWJ; Arits AHMM; de Rooij MJM; Kessels JPHM; Essers BAB; Mosterd K
    J Am Acad Dermatol; 2024 Jan; 90(1):58-65. PubMed ID: 37666424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
    Lawrie TA; Nordin A; Chakrabarti M; Bryant A; Kaushik S; Pepas L
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011837. PubMed ID: 26728940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for melanoma in situ, including lentigo maligna.
    Tzellos T; Kyrgidis A; Mocellin S; Chan AW; Pilati P; Apalla Z
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010308. PubMed ID: 25526608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
    Aguilar M; de Troya M; Martin L; Benítez N; González M
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1431-6. PubMed ID: 20456549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up.
    Ko DY; Kim KH; Song KH
    Br J Dermatol; 2014 Jan; 170(1):165-72. PubMed ID: 24102369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease.
    Morton CA; Whitehurst C; Moseley H; McColl JH; Moore JV; Mackie RM
    Br J Dermatol; 1996 Nov; 135(5):766-71. PubMed ID: 8977678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablative fractional laser-assisted photodynamic therapy provides superior long-term efficacy compared with standard methyl aminolevulinate photodynamic therapy for lower extremity Bowen disease.
    Kim HJ; Song KH
    J Am Acad Dermatol; 2018 Nov; 79(5):860-868. PubMed ID: 29857012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light therapies for acne.
    Barbaric J; Abbott R; Posadzki P; Car M; Gunn LH; Layton AM; Majeed A; Car J
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD007917. PubMed ID: 27670126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy with epidermal ablation using fractional carbon-dioxide laser in the treatment of Bowen's disease: A case series.
    Sung JM; Kim YC
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():84-85. PubMed ID: 28457851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photosensitizers and light sources for photodynamic therapy of the Bowen's disease.
    Calin MA; Diaconeasa A; Savastru D; Tautan M
    Arch Dermatol Res; 2011 Apr; 303(3):145-51. PubMed ID: 21286736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease.
    Salim A; Leman JA; McColl JH; Chapman R; Morton CA
    Br J Dermatol; 2003 Mar; 148(3):539-43. PubMed ID: 12653747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for cutaneous molluscum contagiosum.
    van der Wouden JC; van der Sande R; Kruithof EJ; Sollie A; van Suijlekom-Smit LW; Koning S
    Cochrane Database Syst Rev; 2017 May; 5(5):CD004767. PubMed ID: 28513067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.